Poxviral ankyrin proteins

Viruses

Volumn 7, Issue 2, 2015, Pages 709-738

  Herbert, Michael H ^a   Squire, Christopher J ^a   Mercer, Andrew A ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Ankyrin; Evolution; F box; NF B; Phylogenetics; Poxvirus; Ubiquitin

Indexed keywords

ANKYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UBIQUITIN PROTEIN LIGASE; VIRUS PROTEIN; PROTEIN BINDING; VIRAL PROTEIN;

CHORDOPOXVIRINAE; COWPOX VIRUS; DNA BINDING MOTIF; EUKARYOTIC CELL; F BOX MOTIF; FOWLPOX VIRUS; HOST RANGE; HUMAN; MYXOMA VIRUS; NEDDYLATION; NONHUMAN; PHYLOGENY; POXVIRIDAE; PROKARYOTIC CELL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; RING FINGER MOTIF; UBIQUITINATION; VIRUS GENE; VIRUS GENOME; CHEMISTRY; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

POXVIRIDAE; VERTEBRATA;

AMINO ACID MOTIFS; ANKYRIN REPEAT; ANKYRINS; F-BOX MOTIFS; HOST-PATHOGEN INTERACTIONS; NF-KAPPA B; PHYLOGENY; POXVIRIDAE; PROTEIN BINDING; VIRAL PROTEINS;

EID: 84923005233     PISSN: 19994915     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v7020709     Document Type: Review

References (147)

1. Iyer, L.M.; Aravind, L.; Koonin, E.V. Common origin of four diverse families of large eukaryotic DNA viruses. J. Virol. 2001, 75, 11720–11734.
2. Iyer, L.M.; Balaji, S.; Koonin, E.V.; Aravind, L. Evolutionary genomics of nucleo-cytoplasmic large DNA viruses. Virus Res. 2006, 117, 156–184.
3. Moss, B. Poxviridae. In Fields Virology; Knipe, D.M., Howley, P.M., Eds.; Lippincott, Williams and Wilkins: Philadelphia, PA, USA, 2013; pp. 2129–2159.
4. Smith, G.L.; McFadden, G. Smallpox: Anything to declare? Nat. Rev. Immun. 2002, 2, 521–527.
5. Henderson, D.A. The eradication of smallpox—An overview of the past, present, and future. Vaccine 2011, 295, D7–D9.
6. Spiesschaert, B.; McFadden, G.; Hermans, K.; Nauwynck, H.; van de Walle, G.R. The current status and future directions of myxoma virus, a master in immune evasion. Vet. Res. 2011, 42, e76.
7. Damon, I.K. Status of human monkeypox: Clinical disease, epidemiology and research. Vaccine 2011, 295, D54–D59.
8. Essbauer, S.; Pfeffer, M.; Meyer, H. Zoonotic poxviruses. Vet. Microbiol. 2010, 140, 229–236.
9. Lewis-Jones, S. Zoonotic poxvirus infections in humans. Curr. Opin. Infect. Dis. 2004, 17, 81–89.
10. Gubser, C; Hué, S.; Kellam, P.; Smith, G.L. Poxvirus genomes: A phylogenetic analysis. J. Gen. Virol. 2004, 85, 105–117.
11. Lefkowitz, E.J.; Wang, C.; Upton, C. Poxviruses: Past, present and future. Virus Res. 2006, 117, 105–118.
12. Upton, C.; Slack, S.; Hunter, A.L.; Ehlers, A.; Roper, R.L. Poxvirus orthologous clusters: Toward defining the minimum essential poxvirus genome. J. Virol. 2003, 77, 7590–7600.
13. Bratke, K.A.; McLysaght, A. Identification of multiple independent horizontal gene transfers into poxviruses using a comparative genomics approach. BMC Evol. Biol. 2008, 8, e67.
14. Stabenow, J.; Buller, M.; Schriewer, J.; West, C.; Sagartz, J.E.; Parker, S. A mouse model of lethal infection for evaluating prophylactics and therapeutics against monkeypox virus. J. Virol. 2010, 84, 3909–3920.
15. Ha, H.J.; Alley, M.; Howe, L.; Gartrell, B. Evaluation of the pathogenicity of avipoxvirus strains isolated from wild birds in New Zealand and the efficacy of a fowlpox vaccine in passerines. Vet. Microbiol. 2013, 165, 268–274.
16. Mercer, A.A.; Yirrell, D.L.; Reid, H.W.; Robinson, A.J. Lack of cross-protection between vaccinia virus and orf virus in hysterectomy-procured, barrier-maintained lambs. Vet. Microbiol. 1994, 41, 373–382.
17. Alzhanova, D.; Früh, K. Modulation of the host immune response by cowpox virus. Microbes Infect. 2010, 12, 900–909.
18. Barrett, J.W.; Cao, J.-X.; Hota-Mitchell, S.; McFadden, G. Immunomodulatory proteins of myxoma virus. Semin. Immun. 2001, 13, 73–84.
19. Haller, S.L.; Peng, C.; McFadden, G.; Rothenburg, S. Poxviruses and the evolution of host range and virulence. Infect. Genet. Evol. 2014, 21, 15–40.
20. Haig, D.M. Orf virus infection and host immunity. Curr. Opin. Immun. 2006, 19, 127–131.
21. Afonso, C.L.; Tulman, E.R.; Lu, Z.; Zsak, L.; Kutish, G.F.; Rock, D.L. The genome of fowlpox virus. J. Virol. 2000, 74, 3815–3831.
22. Offerman, K.; Carulei, O.; van der Walt, A.P.; Douglass, N.; Williamson, A.-L. The complete genome sequences of poxviruses isolated from a penguin and a pigeon in South Africa and comparison to other sequenced avipoxviruses. BMC Genomics 2014, 15, e463.
23. Tulman, E.R.; Afonso, C.L.; Lu, Z.; Zsak, L.; Kutish, G.F.; Rock, D.L. The genome of canarypox virus. J. Virol. 2004, 78, 353–366.
24. Afonso, C.L.; Tulman, E.R.; Lu, Z.; Zsak, L.; Sandybaev, N.T.; Kerembekova, U.Z.; Zaitsev, V.L.; Kutish, G.F.; Rock, D.L. The genome of camelpox virus. Virology 2002, 295, 1–9.
25. Chen, N.; Danila, M.I.; Feng, Z.; Buller, R.M.L.; Wang, C.; Han, X.; Lefkowitz, E.J.; Upton, C. The genomic sequence of ectromelia virus, the causative agent of mousepox. Virology 2003, 317, 165–186.
26. Goebel, S.J.; Johnson, G.P.; Perkus, M.E.; Davis, S.W.; Winslow, J.P.; Paoletti, E. The complete DNA sequence of vaccinia virus. Virology 1990, 179, 247–266.
27. Massung, R.F.; Liu, L.-I.; Knight, J.C.; Yuran, T.E.; Kerlavage, A.R.; Parsons, J.M.; Venter, J.C.; Esposito, J.J. Analysis of the complete sequence of smallpox variola major strain Bangladesh 1975. Virology 1994, 201, 215–240.
28. Shchelkunov, S.N.; Blinov, V.M.; Sandakhchiev, L.S. Ankyrin-like proteins of variola and vaccinia viruses. FEBS Lett. 1993, 319, 163–165.
29. Afonso, C.L.; Tulman, E.R.; Lu, Z.; Zsak, L.; Osorio, F.A.; Balinsky, C.; Kutish, G.F.; Rock, D.L. The genome of swinepox virus. J. Virol. 2002, 76, 783–790.
30. Afonso, C.L.; Delhon, D.; Tulman, E.R.; Lu, Z.; Zsak, A.; Becerra, V.M.; Zsak, L.; Kutish, G.F.; Rock, D.L. The genome of deerpox virus. J. Virol. 2005, 79, 966–977.
31. Cameron, C.; Hota-Mitchell, S.; Chen, L.; Barrett, J.; Cao, J.-X.; Macaulay, C.; Willer, D.; Evans, D.; McFadden, G. The complete DNA sequence of myxoma virus. Virology 1999, 264, 298–318.
32. Lee, H.-J.; Essani, K.; Smith, G.L. The genome sequence of yaba-like disease virus, a yatapoxvirus. Virology 2001, 281, 170–192.
33. Tulman, E.R.; Afonso, C.L.; Lu, Z.; Zsak, L.; Sur, J.-H.; Sandybaev, N.T.; Kerembekova, U.Z.; Zaitsev, V.L.; Kutish, G.F.; Rock, D.L. The genomes of sheeppox and goatpox viruses. J. Virol. 2002, 76, 6054–6061.
34. Sonnberg, S.; Fleming, S.B.; Mercer, A.A. Phylogenetic analysis of the large family of poxvirus ankyrin-repeat proteins reveals orthologue groups within and across chordopoxvirus genera. J. Gen. Virol.2011, 92, 2596–2607.
35. Hughes, A.L.; Friedman, R. Poxvirus genome evolution by gene gain and loss. Mol. Phylogen. Evol. 2005, 35, 186–195.
36. Delhon, G.; Tulman, E.R.; Afonso, C.L.; Lu, Z.; de la Concha-Bermejillo, A.; Lehmkuhl, H.D.; Piccone, M.E.; Kutish, G.F.; Rock, D.L. Genomes of the parapoxviruses orf virus and bovine papular stomatitis virus. J. Virol. 2004, 78, 168–177.
37. Mercer, A.A.; Ueda, N.; Friederichs, S.-M.; Hofmann, K.; Fraser, K.M.; Bateman, T.; Fleming, S.B. Comparative analysis of genome sequences of three isolates of Orf virus reveals unexpected sequence variation. Virus Res. 2006, 116, 146–158.
38. Hautaniemi, M.; Ueda, N.; Tuimala, J.; Mercer, A.A.; Lahdenpera, J.; McInnes, C.J. The genome of pseudocowpoxvirus: Comparison of a reindeer isolate and a reference strain. J. Gen. Virol. 2010, 91, 1560–1576.
39. Afonso, P.P.; Silva, P.M.; Schnellrath, L.C.; Jesus, D.M.; Hu, J.; Yang, Y.; Renne, R.; Attias, M.; Condit, R.C.; Moussatché, N.; et al. Biological characterization and next-generation genome sequencing of the unclassified cotia virus SPAn232 (Poxviridae). J. Virol. 2012, 86, 5039–5054.
40. Bratke, K.A.; McLysaght, A.; Rothenburg, S. A survey of host range genes in poxvirus genomes. Infect. Genet. Evol. 2013, 14, 406–425.
41. Senkevich, T.G.; Koonin, E.V.; Bugert, J.J.; Darai, G.; Moss, B. The genome of molluscum contagiosum virus: Analysis and comparison with other poxviruses. Virology 1997, 233, 19–42.
42. Afonso, C.L.; Tulman, E.R.; Delhon, G.; Lu, Z.; Viljoen, G.J.; Wallace, D.B.; Kutish, G.F.; Rock, D.L. Genome of crocodilepox virus. J. Virol. 2006, 80, 4978–4991.
43. McInnes, C.J.; Wood, A.R.; Thomas, K.; Sainsbury, A.W.; Gurnell, J.; Dein, J.; Nettleton, P.F. Genomic characterization of a novel poxvirus contributing to the decline of the red squirrel (Sciurus vulgaris) in the UK. J. Gen. Virol. 2006, 87, 2115–2125.
44. Afonso, C.L.; Tulman, E.R.; Lu, Z.; Oma, E.; Kutish, G.F.; Rock, D.L. The genome of Melanoplus sanguinipes entomopoxvirus. J. Virol. 1999, 73, 533–552.
45. Bawden, A.L.; Glassberg, K.J.; Diggans, J.; Shaw, R.; Farmerie, W.; Moyer, R.W. Complete genomic sequence of the Amsacta moorei entomopoxvirus: Analysis and comparison with other poxviruses. Virology 2000, 274, 120–139.
46. Thézé, J.; Takatsuka, J.; Li, Z.; Gallais, J.; Doucet, D.; Arif, B.; Nakai, M.; Herniou, E.A. New insights into the evolution of Entomopoxvirinae from the complete genome sequences of four entomopoxviruses infecting Adoxophyes honmai, Choristoneura biennis, Choristoneura rosaceana, and Mythimna separata. J. Virol. 2013, 87, 7992–8003.
47. Mosavi, L.K.; Cammett, T.J.; Desrosiers, D.C.; Peng, Z.-Y. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 2004, 13, 1435–1448.
48. Jernigan, K.K.; Bordenstein, S.R. Ankyrin domains across the Tree of Life. Peer J. 2014, 264, 1–14.
49. Breeden, L.; Nasmyth, K. Similarity between cell-cycle genes of budding yeast and fission yeast and the Notch gene of Drosophila. Nature 1987, 329, 651–654.
50. Lux, S.; John, K.M.; Bennett, V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue differentiation and cell-cycle control proteins. Nature 1990, 344, 35–42.
51. Bennett, V.; Baines, A.J. Spectrin and ankyrin-based pathways: Metazoan inventions for integrating cells into tissues. Phys. Rev. 2001, 81, 1353–1392.
52. Michaely, P.; Tomchick, D.R.; Machius, M.; Anderson, R.G.W. Crystal structure of a 12 ANK repeat stack from human ankyrinR. Peer J. 2002, 21, 6387–6396.
53. Cunha S.R.; Mohler, P.J. Ankyrin protein networks in membrane formation and stabilization. J. Cell. Mol. Med. 2009, 13, 4364–4376.
54. Cai, X.; Zhang, Y. Molecular evolution of the ankyrin gene family. Mol. Biol. Evol. 2006, 23, 550–558.
55. Bennett, V.; Lorenzo, D.N. Spectrin- and ankyrin-based membrane domains and the evolution of vertebrates. Curr. Top. Membr. 2013, 72, 1–37.
56. Gaudet, R. A primer on ankyrin repeat function in TRP channels and beyond. Mol. Biosyst. 2008, 4, 372–379.
57. Li, J.; Mahajan, A.; Tsai, M.-D. Ankyrin repeat: A unique motif mediating protein-protein interactions. Biochemistry 2006, 45, 15168–15178.
58. Li, Y.; Meng, X.; Xiang, Y.; Deng, J. Structure function studies of vaccinia virus host range protein K1 reveal a novel functional surface for ankyrin repeat proteins. J. Virol. 2010, 84, 3331–3338.
59. Meng, X.; Xiang, Y. Vaccinia virus K1L protein supports viral replication in human and rabbit cells through a cell-type-specific set of its ankyrin repeat residues that are distinct from its binding site for ACAP2. Virology 2006, 353, 220–233.
60. Sheng, M.; Kim, E. The SHANK family of scaffold proteins. J. Cell Sci. 2000, 113, 1851–1856.
61. Guilmatre, A.; Huguet, G.; Delorme, R.; Bourgeron, T. The emerging role of SHANK repeat genes in neuropsychiatric disorders. Dev. Neurobiol. 2013, 74, 113–122.
62. Jacobs, M.D.; Harrison, S.C. Structure of an IκBα/NF-κB complex. Cell 1998, 95, 749–758.
63. Huxford, T.; Ghosh, G. A structural guide to proteins of the NF-κB signalling module. Cold Spring Harb. Perspect. Biol. 2009, 1, 1–16.
64. Lubman, O.Y.; Kopan, R.; Waksman, G.; Korole, S. The crystal structure of a partial mouse Notch-1 ankyrin domain: Repeats 4 through 7 preserve an ankyrin fold. Protein Sci. 2005, 14, 1274–1281.
65. Li, J.; Guo, Y. Gankyrin oncoprotein: Structure, function, and involvement in cancer. Curr. Chem. Biol. 2010, 4, 13–19.
66. Hsiao, S.J.; Smith, S. Tankyrase function at telomeres, spindle poles, and beyond. Biochemie 2008, 90, 83–92.
67. Kakinuma, N.; Zhu, Y.; Wang, Y.; Roy, B.C.; Kiyama, R. KANK repeat proteins: Structure, functions and diseases. Cell. Mol. Life Sci. 2009, 66, 2651–2659.
68. Kojic, S.; Radojkovic, D.; Faulkner, G. Muscle ankyrin repeat proteins: Their role in striated muscle function in health and disease. Crit. Rev. Clin. Lab. Sci. 2011, 48, 269–294.
69. Li, M.; Yu, Y.; Yang, J. Structural biology of TRP channels. Adv. Exp. Med. Biol. 2011, 704, 1–23.
70. Al-Khodor, S.; Price, C.T.; Kalia, A.; Kwaik, Y.A. Functional diversity of ankyrin repeats in microbial proteins. Trends Micro 2010, 18, 132–139.
71. Mercer, A.A.; Fleming, S.B; Ueda, N. F-Box-like domains are present in most poxvirus ankyrin repeat proteins. Virus Genes 2005, 31, 127–133.
72. Bai, C.; Sen, P.; Hofmann, K.; Ma, L.; Goebl, M.; Harper, J.W.; Elledge, S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 1996, 86, 263–274.
73. Cardozo, T.; Pagano, M. The SCF ubiquitin ligase: Insights into a molecular machine. Nat. Rev. Mol. Cell Biol. 2004, 5, 739–751.
74. Sarikas, A.; Hartmann, T.; Pan, Z.-Q. The cullin protein family. Genome Biol. 2011, 12, 220–232.
75. Jin, J.; Cardozo, T.; Lovering, R.C.; Elledge, S.J.; Pagano, M.; Harper, J.W. Systematic analysis and nomenclature of mammalian F-box proteins. Genes Dev. 2004, 18, 2573–2580.
76. Duda, D.M.; Borg, L.A.; Scott, D.C.; Hunt, H.W.; Hammel, M.; Schulman, B.A. Structural insights into NEDD8 activation of cullin-RING ligases: Conformational control of conjugation. Cell 2008, 19, 995–1006.
77. Lydeard, J.R.; Schulman, B.A.; Harper, J.W. Building and remodelling Cullin-RING E3 ubiquitin ligases. EMBO Rep. 2013, 14, 1050–1061.
78. Sonnberg, S.; Seet, B.T.; Pawson, T.; Fleming, S.B.; Mercer, A.A. Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. Proc. Natl. Acad. Sci. USA 2006, 105, 10955–10960.
79. Chang, S.-J.; Hsiao, J.-C.; Sonnberg, S.; Chiang, C.-T.; Yang, M.-H.; Tzou, D.-L.; Mercer, A.A.; Chang, W. Poxvirus host range protein CP77 contains an F-box-like domain that is necessary to suppress NF-κB activation by tumor necrosis factor alpha but is independent of its host range function. J. Virol. 2009, 83, 4140–4152.
80. Mohamed, M.R.; Rahmana, M.M.; Lanchbury, J.S.; Shattuck, D.; Neff, C.; Dufford, M.; van Buuren, N.; Fagan, K.; Barry, M.; Smith, S.; et al. Proteomic screening of variola virus reveals a unique NF-κB inhibitor that is highly conserved among pathogenic orthopoxviruses. Proc. Natl. Acad. Sci. USA 2009, 106, 9045–9050.
81. Mohamed, M.R.; Rahmana, M.M.; Rice, A.; Moyer, R.W.; Werden, S.J.; McFadden, G. Cowpox virus expresses a novel ankyrin repeat NF-κB inhibitor that controls inflammatory cell influx into virus-infected tissues and is critical for virus pathogenesis. J. Virol. 2009, 83, 9223–9236.
82. Sperling, K.M.; Schwantes, A.; Schnierle, B.S.; Sutter, G. The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex. Virology 2008, 374, 234–239.
83. Van Buuren, N.; Couturier, B.; Xiong, Y.; Barry, M. Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex. J. Virol. 2008, 83, 9917–9927.
84. Blanié, S.; Gelfi, J.; Bertagnoli, S.; Camus-Bouclainville, C. MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection. Virol. J. 2010, 7, 56–61.
85. Werden, S.J.; Lanchbury, J.; Shattuck, D.; Neff, C.; Dufford, M.; McFadden, G. The myxoma virus M-T5 ankyrin repeat host range protein is a novel adaptor that coordinately links the cellular signalling pathways mediated by Akt and Skp1 in virus-infected cells. J. Virol. 2009, 83, 12068–12083.
86. Sonnberg, S.; Fleming, S.B.; Mercer, A.A.G. A truncated two-α-helix F-box present in poxvirus ankyrin-repeat proteins is sufficient for binding the SCF1 ubiquitin ligase complex. J. Gen. Virol. 2009, 90, 1224–1228.
87. Schulman, B.A.; Carrano, A.C.; Jeffrey, P.D.; Bowen, Z.; Kinnucan, E.R.E.; Finnin, M.S.; Elledge, S.J.; Harper, J.W.; Pagano, M.; Pavletich, N.P. Insights into SCF ubiquitin ligases from the structure of the Skp1-Skp2 complex. Nature 2000, 408, 381–386.
88. Wu, G.; Xu, G.; Schulman, B.A.; Jeffrey, P.D.; Harper, J.W.; Pavletich, N.P. Structure of a β-TrCP1-Skp1-β-catenin complex: Destruction motif binding and lysine specificity of the SCF β–T rCP 1 ubiquitin ligase. Mol. Cell 2003, 11, 1445–1456.
89. Sutter, G.; Ramsey-Ewing, A.; Rosales, R.; Moss, B. Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. J. Virol. 1994, 68, 4109–4116.
90. Perkus, M.E.; Goebel, S.J.-J.; Davis, S.W.; Johnson, G.P.; Limbach, K.; Norton, E.K.; Paolelti, E. Vaccinia virus host range genes. Virology 1990, 179, 276–286.
91. Muniz, J.R.C.; Guo, K.; Kershaw, N.J.; Ayinampudi, V.; von Delft, F.; Babon, J.J.; Bullock, A.N. Molecular architecture of the ankyrin SOCS box family of Cul5-dependent E3 ubiquitin ligases. J. Mol. Biol. 2013, 425, 3166-3177.
92. Hendrickson, R.C.; Wang, C.; Hatcher, E.L.; Lefkowitz, E.J. Orthopoxvirus genome evolution: The role of gene loss. Viruses 2010, 2, 1933–1967.
93. Hughes, A.L.; Irausquin, S.; Friedman, R. The evolutionary biology of poxviruses. Infect. Genet. Evol. 2010, 10, 50–59.
94. Antoine, G.; Scheiflinger, F.; Dorner, F.; Falkner, F.G. The complete genomic sequence of the modified vaccinia Ankara strain: Comparison with other orthopoxviruses. Virology 1998, 244, 365–396.
95. Mossman, K.; Lee, S.F.; Barry, M.; Boshkov, L.; McFadden, G. Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 1996, 70, 4394–4410.
96. Marschang, R.E. Viruses infecting reptiles. Viruses 2011, 3, 2087–2126.
97. Odom, M.R.; Hendrickson, R.C.; Lefkowitz, E.J. Poxvirus protein evolution: Family wide assessment of possible horizontal gene transfer events. Virus Res. 2009, 144, 233–249.
98. Werren, J.H.; Richards, S.; Desjardins, C.A.; Niehuis, O.; Gadau, J.; Colbourne, J.K.; Beukeboom, L.W.; Desplan, C.; Elsik, C.G.; Grimmelikhuijzen, C.J.P.; et al. Functional and evolutionary insights from the genomes of three parasitoid Nasonia species. Science 2010, 327, 343–347.
99. Cho, N.-H.; Kim, H.-R.; Lee, J.-H.; Kim, S.-Y.; Kim, J.; Cha, S.; Kim, S.-Y.; Darby, A.C.; Fuxelius, H.H.; Yin, J.; et al. The Orientia tsutsugamushi genome reveals massive proliferation of conjugative type IV secretion system and host-cell interaction genes. Proc. Natl. Acad. Sci. USA 2007, 104, 7981–7986.
100. Min, C.-K.; Kwon, Y.-J.; Ha, N.-Y.; Cho, B.A; Kim, J.-M.; Kwon, E.-K.; Kim, Y.-S.; Choi, M.-S.; Kim, I.-S.; Cho, N.-H. Multiple Orientia tsutsugamushi ankyrin repeat proteins interact with SCF1 ubiquitin ligase complex and eukaryotic elongation factor 1a. PLOS ONE 2014, 9, e105652.
101. Lamb, S.A.; Rahman, M.M.; McFadden, G. Recombinant myxoma virus lacking all poxvirus ankyrin-repeat proteins stimulates multiple cellular anti-viral pathways and exhibits a severe decrease in virulence. Virology 2014, 464–465, 134–145.
102. Laidlaw, S.M.; Skinner, M.A. Comparison of the genome sequence of FP9, an attenuated, tissue culture-adapted European strain of fowlpox virus, with those of virulent American and European viruses. J. Gen. Virol. 2004, 85, 305–322.
103. Fleming, S.B.; Lyttle, D.J.; Sullivan, J.T.; Andrew, A.; Mercer, A.A.; Robinson, A.J. Genomic analysis of a transposition-deletion variant of orf virus reveals a 3.3 kbp region of non-essential DNA. J. Gen. Virol. 1995, 76, 2969–2978.
104. Drillien, R.; Koehren, F.; Kirn, A. Host range deletion mutant of vaccinia virus defective in human cell. Virology 1981, 111, 488–499.
105. Bradley, R.R.; Terajima, M. Vaccinia virus K1L protein mediates host-range function in RK-13 cells via ankyrin repeat and may interact with a cellular GTPase-activating protein. Virus Res. 2005, 114, 104–112.
106. Meng, X.; Jiang, C.; Arsenio, J.; Dick, K.; Cao, J.; Xiang, Y. Vaccinia virus K1L and C7L inhibit antiviral activities induced by type I interferons. J. Virol. 2009, 83, 10627–10636.
107. Shisler, J.L.; Jin, X.-L. The vaccinia virus K1L gene product inhibits host NF-κB activation by preventing IκBα degradation. J. Virol. 2004, 78, 3553–3560.
108. Willis, K.L.; Patel, S.; Xiang, Y.; Shisler, J.-L. The effect of the vaccinia K1 protein on the PKR-eIF2α pathway in RK13 and HeLa cells. Virology 2009, 394, 73–81.
109. Willis, K.L.; Langland, J.O.; Shisler, J.L. Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-κB activation, when the K1 protein is absent or mutated. J. Biol. Chem. 2011, 286, 7765-7778.
110. Brady, G.; Bowie, A.G. Innate immune activation of NF-κB and its antagonism by poxviruses. Cytokine Growth Factor Rev. 2014, 25, 611–620.
111. Mohamed, M.R.; McFadden, G. NF-κB inhibitors: Strategies from poxviruses. Cell Cycle 2009, 8, 3125–3132.
112. McFadden, G. Poxvirus tropism. Nat. Rev. Microbiol. 2005, 3, 201–213.
113. Willems, A.R.; Schwab, M.; Tyers, M. A hitchhiker’s guide to the cullin ubiquitin ligases: SCF and its kin. Biochim. Biophys. Acta 2004, 1695, 133–170.
114. Petroski, M.D.; Deshaies, R.J. Function and regulation of Cullin-Ring ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 2005, 6, 9–20.
115. Johnston, J.B.; Wang, G.; Barrett, J.W.; Nazarian, S.H.; Colwill, K.; Moran, M.; McFadden, G. Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell Cullin-1. J. Virol. 2005, 79, 10750–10763.
116. Burles, K.; van Buuren, N.; Barry, M. Ectromelia virus encodes a family of ANK/F-box proteins that regulate NFκB. Virology 2014, 468–470, 351–362.
117. Buttigieg, K.; Laidlaw, S.M.; Ross, C.; Davies, M.; Goodbourn, S.; Skinner, M.A. Genetic screen of a library of chimeric poxviruses identifies an ankyrin repeat protein involved in resistance to the avian type I interferon response. J. Virol. 2013, 87, 5028–5040.
118. Hsiao, J.-C.; Chao, C.-C.; Young, M.-J.; Chang, Y.-T.; Cho, E.-C.; Chang, W. A poxvirus host range protein, CP77, binds to a cellular protein, HMG20A, and regulates its dissociation from the vaccinia virus genome in CHO-K1 cells. J. Virol. 2006, 80, 7714–7728.
119. Blanié, S.; Mortier, J.; Delverdier, M.; Bertagnoli, S.; Camus-Bouclainville, C. M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit. Vet. Res. 2009, 40, e11.
120. Lacek, K.; Bauer, B.; Bienkowska-Szewczyk, K.; Rziha, H.-J. Orf virus (ORFV) ANK-1 protein mitochondrial localization is mediated by ankyrin repeat motifs. Virus Genes 2014, 49, 68–79.
121. Sperling, K.M.; Schwantes, A.; Staib, C.; Schnierle, B.S.; Sutter, G. The orthopoxvirus 68-kilodalton ankyrin-like protein is essential for DNA replication and complete gene expression of modified vaccinia virus Ankara in non-permissive human and murine cells. J. Virol. 2009, 83, 6029–6038.
122. Laidlaw, S.M.; Robey, R.; Davies, M.; Giotis, E.S.; Ross, C.; Davies, M.; Buttigieg, K.; Goodbourn, S.; Skinner, M.A. Genetic screen of a mutant poxvirus library identifies an ankyrin repeat protein involved in blocking induction of avian type I interferon. J. Virol. 2013, 87, 5041–5052.
123. Camus-Bouclainville, C.; Fiette, L.; Bouchiha, S.; Pignolet, B.; Counor, D.; Filipe, C.; Gelfi, J.; Messud-Petit, F. A virulence factor of myxoma virus colocalizes with NF-κB in the nucleus and interferes with inflammation. J. Virol. 2004, 78, 2510–2516.
124. Hiscott, J.; Nguyen, T.L.A.; Arguello, M.; Nakhaei, P.; Paz, S. Manipulation of the nuclear factor-κB pathway and the innate immune response by viruses. Oncogene 2006, 25, 6844–6867.
125. Le Negrate, G. Viral interference with innate immunity by preventing NF-κB activity. Cell. Microbiol. 2012, 14, 168–181.
126. Ghosh, S.; May, M.J.; Kopp, E.B. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 1998, 16, 225–260.
127. McInnes, C.J.; Wood, A.R.; Mercer, A.A. Orf virus encodes a homolog of the vaccinia virus interferon-resistance gene E3L. Virus Genes 1998, 17, 107–115.
128. Diel, D.G.; Delhon, G.; Luo, S.; Flores, E.F.; Rock, D.L. A novel inhibitor of the NF-κB signalling pathway encoded by the parapoxvirus orf virus. J. Virol. 2010, 84, 3962–2973.
129. Diel, D.G.; Luo, S.; Delhon, G.; Peng, Y.; Flores, E.F.; Rock, D.L. A nuclear inhibitor of NF-κB encoded by a poxvirus. J. Virol. 2011, 85, 264–275.
130. Diel, D.G.; Luo, S.; Delhon, G.; Peng, Y.; Flores, E.F.; Rock, D.L. Orf virus ORFV121 encodes a novel inhibitor of NF-κB that contributes to virus virulence. J. Virol. 2011, 85, 2037–2049.
131. Aravalli, R.N.; Hu, S.; Lokensgard, J.R. Inhibition of Toll-like receptor signalling in primary murine microglia. J. Neuroimmune Pharmacol. 2008, 3, 5–11.
132. Van Buuren, N.; Burles, K.; Schriewer, J.; Mehta, N.; Parker, S.; Buller, R.M.; Barry, M. EVM005: An ectromelia-encoded protein with dual roles in NF-κB inhibition and virulence. PLOS Pathog. 2014, 10, e1004326.
133. Wang, G.; Barrett, J.W.; Stanford, M.; Werden, S.J.; Johnston, J.B.; Gao, X.; Su, M.; Cheng, J.Q.; McFadden, G. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Proc. Natl. Acad. Sci. USA 2006, 103, 4640–4645
134. Werden, S.J.; Barrett, J.W.; Wang, G.; Stanford, M.M.; McFadden, G. M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A. J. Virol. 2007, 81, 2340–2348.
135. Pierce, N.W.; Lee, J.E.; Liu, X.; Sweredoski, M.J.; Graham, R.L.J.; Larimore, E.A.; Rome, M.; Zheng, N.; Clurman, B.E.; Hess, S.; et al. Cand1 promotes assembly of new SCF complexes through dynamic exchange of F-Box proteins. Cell 2013, 153, 206–215.
136. Sullivan, J.T.; Fraser, K.M.; Fleming, S.B.; Robinson, A.J.; Mercer, A.A. Sequence and transcriptional analysis of an orf virus gene encoding ankyrin-like repeat sequences. Viruses Genes 1995, 9, 277–282.
137. Wood, A.R.; McInnes, C.J. Transcript mapping of the early genes of Orf virus. J. Gen. Virol. 2003, 84, 2993–2998.
138. Barry, M.; van Buuren, N.; Burles, K.; Mottet, K.; Wang, Q.; Teale, A. poxvirus exploitation of the ubiquitin-proteasome system. Viruses 2010, 2, 2356–2380.
139. Wang, Q.; Burles, K.; Couturier, B.; Randall, C.M.H.; Shisler, J.; Barry, M. Ectromelia virus encodes a BTB/Kelch Protein, EVM150, that inhibits NF-κB signaling. J. Virol. 2014, 84, 4853–4865.
140. Mottet, K.; Bareiss, B.; Milne, C.D.; Barry, M. The poxvirus encoded ubiquitin ligase, p28, is regulated by proteasomal degradation and autoubiquitination. Virology 2014, 468–470, 363–378.
141. Mansouri, M.; Bartee, E.; Gouveia, K.; Hovey Nerenberg, B.T.; Barrett, J.; Thomas, L.; Thomas, G.; McFadden, G.; Früh, K. The PHD/LAP-domain protein M153R of myxomavirus is an ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J. Virol. 2003, 77, 1427–1440.
142. Mo, M.; Fleming, S.B.; Mercer, A.A. Cell cycle deregulation by a poxvirus partial mimic of anaphase-promoting complex subunit 11. Proc. Natl. Acad. Sci. USA 2009, 106, 19527–19532.
143. Mo, M.; Fleming, S.B.; Mercer, A.A. Orf virus cell cycle regulator, PACR, competes with subunit 11 of the anaphase promoting complex for incorporation into the complex. J. Gen Virol. 2010, 91, 3010–3015.
144. Teale, A.; Campbell, S.; van Buuren, N.; Magee, W.C.; Watmough, K.; Couturier, B.; Shipclark, R.; Barry, M. Orthopoxviruses require a functional ubiquitin-proteasome system for productive replication. J. Virol. 2009, 83, 2099–2108.
145. Satheshkumar, P.S.; Anton, L.C.; Sanz, P.; Moss, B. Inhibition of the ubiquitin-proteasome system prevents vaccinia virus DNA replication and expression of intermediate and late genes. J. Virol. 2009, 83, 2469–2479.
146. Mercer, J.; Snijder, B.; Sacher, R.; Burkard, C.; Bleck, C.K.E.; Stahlberg, H.; Pelkmans, L.; Helenius, A. RNAi screening reveals proteasome- and Cullin3-dependent stages in vaccinia virus infection. Cell Rep. 2012, 2, 1036–1047.
147. Schmidt, F.I.; Bleck, C.K.E.; Reh, L.; Novy, K.; Wollscheid, B.; Helenius, A.; Stahlberg, H.; Mercer, J.A. Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies. Cell Rep. 2013, 4, 464–476.